查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045894

動物創傷護理市場－全球產業規模、佔有率、趨勢、機會與預測：按產品、按動物分類，2021-2031年

Animal Wound Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球動物創傷護理市場預計將從 2025 年的 27.1 億美元成長到 2031 年的 37.9 億美元，複合年成長率為 5.75%。

該市場涵蓋種類繁多的醫療設備和產品，例如縫合線、組織黏合劑和先進敷料，這些產品專為治療牲畜和伴侶動物的急性和慢性創傷而設計。推動這一市場成長的關鍵因素包括全球寵物飼養率的上升以及飼主越來越願意投資於高品質的獸醫服務。此外，術後護理需求的不斷成長以及獸醫手術設施的擴建，也積極推動了對有效傷口管理解決方案的需求，而這與其它技術進步無關。

市場概覽
預測期 2027-2031
市場規模：2025年 27.1億美元
市場規模：2031年 37.9億美元
複合年成長率：2026-2031年 5.75%
成長最快的細分市場 伴侶動物
最大的市場 北美洲

然而，這個市場面臨著一個重大障礙：高昂的高級獸醫護理費用可能會限制經濟條件較差的飼主獲得此類服務。儘管該行業已有大量資金流入，但這一經濟障礙依然存在。根據美國寵物用品協會統計，2024年美國獸醫護理和產品銷售的總支出約為398億美元。雖然這些數據顯示市場潛力巨大，但也凸顯了經濟壓力，這些壓力可能會阻礙價格敏感地區高階創傷護理產品的廣泛應用。

市場促進因素

伴侶動物數量的增加以及寵物「擬人化」趨勢的興起，顯著推動了動物創傷護理產品的需求。隨著飼主越來越將寵物視為家庭成員，他們帶寵物去獸醫院進行傷口治療和擇期手術的次數也日益頻繁，這直接導致了醫用紡織品、縫合線和組織黏合劑的使用量增加。這項人口結構變化得到了近期行業數據的佐證。根據歐洲寵物食品聯合會（FEDIAF European Pet Food）於2024年6月發布的《2024年事實與數據》報告，歐洲約有9,100萬戶家庭至少擁有一隻寵物，這為全部區域的獸醫服務和傷口護理耗材帶來了持續的基本需求。

寵物保險和賠償計劃的日益普及是推動這一趨勢的次要因素，因為它減輕了飼主在獸醫護理方面的財務負擔。自付費用的減少使得獸醫專業人員能夠開立最佳治療方法，例如先進的敷料和再生醫學療法，而這些方案原本可能因費用限制而被拒絕。保險業的強勁表現也支撐了這一趨勢。北美寵物健康保險協會 (NAPHIA) 在 2024 年 5 月發布的《2024 年產業狀況報告》中指出，北美寵物保險保費總收入達到 42.7 億美元。此外，英國保險協會 (ABI) 也指出，寵物保險公司在 2024 年支付了創紀錄的 10 億英鎊理賠款，進一步印證了全球獸醫護理資金的不斷成長。

市場挑戰

高昂的獸醫護理費用是全球動物創傷護理市場成長的主要障礙。儘管該行業提供有效的產品來處理急性和慢性創傷，但這些治療的經濟負擔往往迫使畜牧養殖戶和寵物飼主選擇價格較低的替代方案。當動物需要長期照護或頻繁更換繃帶時，這種價格敏感度尤其明顯，導致他們不願意投資昂貴的醫療設備。因此，在獸醫服務成本被認為超過專業傷口護理價值的地區，市場滲透率受到限制。

寵物飼主面臨的經濟壓力與這些產品的供應有限有直接關係。根據英國保險協會（ABI）統計，2024年寵物保險賠償總額將達到創紀錄的10億英鎊，主要是因為獸醫治療和藥物成本不斷上漲所致。日益沉重的經濟負擔導致治療決策更取決於成本而非臨床必要性。因此，儘管獸醫護理需求不斷成長，但製造商卻難以在注重成本的細分市場中擴張，拖累了整體市場收入。

市場趨勢

再生醫學和幹細胞療法的快速發展標誌著市場的重要轉捩點，動物慢性疾病的治療正從症狀治療轉向根治性。這一趨勢的特點是，大量資本投資湧入生物技術公司，這些公司致力於開發針對貓骨關節炎和慢性齦口炎等疾病的現成、物種特異性細胞療法。與傳統藥物不同，這些生物治療方法直擊組織損傷的根本原因，贏得了投資者的極大信心，並推動了先進治療方法的大規模應用。例如，Gallant Therapeutics在2025年6月的新聞稿中宣布，已完成1,800萬美元的B輪融資，用於其同種異體幹細胞產品線的商業化，旨在推動這些新型再生醫學解決方案的大眾市場應用。

隨著監管機構和獸醫積極應對抗菌素抗藥性（AMR），非抗生素傷口管理策略的出現正在從根本上重塑產品系列。這種壓力迫使製造商創新研發替代生物活性材料，例如含銀敷料、醫用蜂蜜和抗菌肽，這些材料無需依賴傳統藥物即可控制感染。這種轉變造成了治療缺口，但替代療法正在填補這一缺口，傳統藥物使用的急劇下降就證明了這一點。根據英國獸藥協會（VMD）於2025年11月發布的《英國獸醫抗生素抗藥性策略2024》（UK-VARSS 2024）報告，肉類用獸用抗生素的劑量已降至15.6毫克/公斤的歷史新低，這表明創新型非抗生素創傷護理技術擁有巨大的市場機會，可以取代受監管的藥物。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球動物創傷護理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（外科創傷護理產品（縫合線和縫合釘、組織黏合劑、密封劑、黏合劑）、高級創傷護理產品（泡棉敷料、親水膠體敷料、膜敷料、水凝膠敷料、其他高級敷料）、傳統創傷護理產品（膠帶、敷料、繃帶、吸收劑、其他傳統創傷護理產品）、治療器材）
    • 依動物類型（伴侶動物（貓、狗、馬和其他伴侶動物）、牲畜（牛、豬和其他牲畜））
    • 依最終使用者（醫院/診所、居家照護、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美動物創傷護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲動物創傷護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區動物創傷護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲動物創傷護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美動物創傷護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球動物創傷護理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Elanco Animal Health
  • Ethicon, Inc.
  • Medtronic PLC
  • B. Braun Melsungen AG
  • Jorgen Kruuse A/S
  • Dechra Pharmaceuticals
  • Sonoma Pharmaceuticals Inc.
  • Neogen Corporation
  • Jazz Medical, LLC
  • Prima-Vet Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20030

The Global Animal Wound Care Market is projected to expand from USD 2.71 Billion in 2025 to USD 3.79 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 5.75%. This market encompasses a range of medical devices and products, including sutures, tissue adhesives, and advanced dressings, specifically engineered for treating acute and chronic injuries in livestock and companion animals. Key factors driving this growth include the rising global rate of pet adoption and the increasing willingness of owners to invest in premium veterinary healthcare. Additionally, the growing necessity for post-operative care and the expansion of veterinary surgical facilities actively bolster the demand for effective wound management solutions, independent of other technological developments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.71 Billion
Market Size 2031USD 3.79 Billion
CAGR 2026-20315.75%
Fastest Growing SegmentCompanion Animal
Largest MarketNorth America

However, the market confronts a significant hurdle regarding the high costs linked to advanced veterinary treatments, which can limit accessibility for financially constrained owners. This economic barrier exists despite the substantial capital flowing into the sector; according to the American Pet Products Association, United States expenditures on veterinary care and product sales totaled approximately $39.8 billion in 2024. While these figures indicate strong market potential, they simultaneously highlight the financial pressures that could hinder the widespread adoption of premium wound care products in regions where price sensitivity is a major factor.

Market Driver

The increasing adoption of companion animals, combined with the trend of pet humanization, significantly drives the demand for animal wound care products. As owners increasingly regard their pets as integral family members, the frequency of veterinary visits for treating traumatic injuries and performing elective surgeries rises, directly necessitating the use of medical textiles, sutures, and tissue adhesives. This demographic shift is supported by recent industry data; according to the 'Facts & Figures 2024' report by FEDIAF EuropeanPetFood in June 2024, approximately 91 million households in Europe owned at least one pet, creating a sustained baseline demand for veterinary services and wound management consumables across the region.

The growing reach of pet insurance and reimbursement policies serves as a secondary catalyst by alleviating the financial burden of veterinary procedures on animal owners. Reduced out-of-pocket expenses allow veterinary professionals to prescribe optimal treatments, such as advanced dressings and regenerative therapies, which might otherwise be refused due to cost constraints. This trend is demonstrated by the robust performance of the insurance sector; the North American Pet Health Insurance Association reported in its 'State of the Industry Report 2024' (May 2024) that total premium volume for pet insurance in North America reached $4.27 billion. Furthermore, the Association of British Insurers noted that pet insurers paid out a record £1 billion in claims in 2024, underscoring the expanding financial resources supporting veterinary interventions globally.

Market Challenge

The substantial costs associated with advanced veterinary treatments present a major barrier to the growth of the global animal wound care market. Although the industry provides effective products for managing acute and chronic injuries, the financial burden of these treatments often compels livestock producers and pet owners to choose less expensive alternatives. This price sensitivity is particularly pronounced when animals require long-term care or frequent dressing changes, resulting in a hesitation to adopt premium medical devices. Consequently, market penetration is restricted in regions where the cost of veterinary services exceeds the perceived value of specialized wound management.

The economic pressure on animal owners is directly linked to the limited uptake of these products. According to the Association of British Insurers, the total value of pet insurance claims reached a record £1 billion in 2024, a figure largely driven by the escalating costs of veterinary procedures and medication. This rising financial load creates an environment where cost often dictates the course of treatment rather than clinical necessity. As a result, manufacturers struggle to scale their operations in cost-conscious segments, which dampens overall market revenue despite the growing need for animal healthcare.

Market Trends

The accelerated adoption of regenerative medicine and stem cell therapies marks a pivotal shift in the market, transitioning from symptomatic management to curative solutions for chronic animal conditions. This trend is defined by significant capital investments in biotechnology firms developing off-the-shelf, species-specific cell therapies for ailments such as osteoarthritis and feline chronic gingivostomatitis. Unlike traditional pharmaceuticals, these biological treatments target the root causes of tissue damage, attracting substantial investor confidence and enabling the industrial scaling of advanced therapeutic modalities. For example, Gallant Therapeutics announced in a June 2025 press release that it secured $18 million in Series B funding to commercialize its allogeneic stem cell pipeline, specifically targeting the mass market distribution of these novel regenerative solutions.

The emergence of non-antibiotic antimicrobial wound management strategies is fundamentally reshaping product portfolios as regulatory bodies and veterinarians actively combat antimicrobial resistance (AMR). This pressure drives manufacturers to innovate with alternative bioactive materials, such as silver-infused dressings, medical-grade honey, and antimicrobial peptides, which offer infection control without relying on conventional drug classes. This transition is creating a therapeutic void that alternative therapies are now filling, evidenced by a sharp decline in traditional drug usage. According to the 'UK-VARSS 2024' report by the Veterinary Medicines Directorate in November 2025, sales of veterinary antibiotics for food-producing animals dropped to a historic low of 15.6 mg/kg, signaling a critical market opportunity for non-antibiotic wound care innovations to replace these restricted pharmaceuticals.

Key Market Players

  • Elanco Animal Health
  • Ethicon, Inc.
  • Medtronic PLC
  • B. Braun Melsungen AG
  • Jorgen Kruuse A/S
  • Dechra Pharmaceuticals
  • Sonoma Pharmaceuticals Inc.
  • Neogen Corporation
  • Jazz Medical, LLC
  • Prima-Vet Inc.

Report Scope

In this report, the Global Animal Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Wound Care Market, By Product

  • Surgical Wound Care Products
  • Advanced Wound Care Products
  • Traditional Wound Care Products
  • Therapy Devices

Animal Wound Care Market, By Animal

  • Companion Animal
  • Livestock

Animal Wound Care Market, By End user

  • Hospitals & Clinics
  • Homecare
  • Others

Animal Wound Care Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Wound Care Market.

Available Customizations:

Global Animal Wound Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Wound Care Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Surgical Wound Care Products (Sutures And Staplers, Tissue Adhesive, Sealants, Glues), Advanced Wound Care Products(Foam Dressings, Hydrocolloid Dressings, Film Dressings, Hydrogel Dressings, Other Advanced Dressings), Traditional Wound Care Products(Tapes, Dressings, Bandages, Absorbents, Other Traditional Wound Care Products), Therapy Devices)
    • 5.2.2. By Animal (Companion Animal (Cats, Dogs, Horses, Another Companion Animal), Livestock (Cattle, Pigs, Other Livestock Animals))
    • 5.2.3. By End user (Hospitals & Clinics, Homecare, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Animal Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Wound Care Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Animal Wound Care Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Animal Wound Care Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal
        • 6.3.3.2.3. By End user

7. Europe Animal Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal
        • 7.3.1.2.3. By End user
    • 7.3.2. France Animal Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Animal Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Animal Wound Care Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Animal Wound Care Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal
        • 7.3.5.2.3. By End user

8. Asia Pacific Animal Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal
        • 8.3.1.2.3. By End user
    • 8.3.2. India Animal Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Animal Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Animal Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Animal
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Animal Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Animal
        • 8.3.5.2.3. By End user

9. Middle East & Africa Animal Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Animal Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Animal Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal
        • 9.3.3.2.3. By End user

10. South America Animal Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Animal Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Animal Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Wound Care Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Elanco Animal Health
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ethicon, Inc.
  • 15.3. Medtronic PLC
  • 15.4. B. Braun Melsungen AG
  • 15.5. Jorgen Kruuse A/S
  • 15.6. Dechra Pharmaceuticals
  • 15.7. Sonoma Pharmaceuticals Inc.
  • 15.8. Neogen Corporation
  • 15.9. Jazz Medical, LLC
  • 15.10. Prima-Vet Inc.

16. Strategic Recommendations

17. About Us & Disclaimer